Categories

Meta

Recent Posts

Archive for the 'Medical Patent' Category

Mirna announces USPTO allows claims to medicinal reference of let-7 miRNA

Posted in Medical Patent on October 21st, 2010

Mirna Therapeutics, Inc. announced today that the USPTO has allowed claims joint to the curative dedication of let-7 in the dictate of oncogenes. The claims develop from from a charter operation that was submitted pre-eminently Yale University and exclusively licensed to Mirna coupled to the pioneering manoeuvre of Dr. Genuine Decrease, Professor of Molecular, Cellular & Developmental Biology at Yale University in Renewed Haven, CT. Let-7 was Read the rest of this entry »

BREAKYL sedative receives European good

Posted in Medical Patent on October 21st, 2010

BioDelivery Sciences Ecumenical, Inc. (Nasdaq: BDSI) and Meda today announced green light allow of BEMA Fentanyl in Europe via the Decentralized Customary, with Germany acting as Relevance Colleague Express. BEMA Fentanyl is indicated against the top brass of breakthrough hurt in opioid fair, mature patients with cancer. Country-wide marketing authorization approvals, enabling commercial sales in each of the 25 lone EU countries, are stylish Read the rest of this entry »

Access submits additional manifest applications in the interest Cobalamin-mediated verbal stimulant utterance technology

Posted in Medical Patent on October 20th, 2010

ACCESS PHARMACEUTICALS, INC. (OTC Account Enter: ACCP), a biopharmaceutical house leveraging its proprietary drug-delivery platforms to expand on treatments in areas of oncology, cancer encouraging be concerned and diabetes, announced it has submitted additional licence applications, covering its Cobalamin-mediated uttered pharmaceutical presentation technology formulations of assorted international top-100 injectable drugs, as a consequence Read the rest of this entry »

USPTO grants two additional patents to Ryogen

Posted in Medical Patent on October 20th, 2010

Ryogen LLC, a genomic probing and increase group focusing on genes with applications in biomedical inquire into, has been awarded two additional patents on magnanimous genes.

“We scheme to go on licensing our scholarly paraphernalia to remedy it ready to the investigating community”

U.S. Prominent No. 7,754,424, titled "Isolated genomic polynucleotide fragments from chromosome 12 that encode generous carboxypeptidase Read the rest of this entry »

Metabolon receives blatant as a remedy for biomarkers to learn PPAR-affecting drugs

Posted in Medical Patent on October 20th, 2010

Metabolon, Inc., leaders in pandemic metabolomics, biomarker conception and biochemical division, announced today the subvention of US Physical 7,807,138 entitled "Biomarkers of Metabolic Responses to Hepatic Drugs". The USPTO awarded the transparent to Metabolon on October 5, 2010. This is the 13th plain issued to Metabolon and the later in its portfolio of biomarker patents.

“Biomarkers of Metabolic Responses to Hepatic Read the rest of this entry »

IMD receives EPO self-evident to NADiA ultra-sensitive protein detection and room phenotyping plank

Posted in Medical Patent on October 19th, 2010

IRIS Supranational, Inc. (Nasdaq:IRIS), a foremost fabricator of automated in-vitro diagnostics systems and consumables as handling in hospitals and commercial laboratories worldwide, and a provider of penetrating value individualized diagnostics testing services to the core its CLIA certified molecular diagnostics laboratory, today announced that Iris Molecular Diagnostics (IMD)has been granted Unequivocal No. EP1842226B1 nigh the European Apparent Read the rest of this entry »

UK Thought-provoking Worth Establishment issues control to entinostat

Posted in Medical Patent on October 19th, 2010

Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology convention, today announced the UK Authority Means Establishment allowed request GB0907347.9 entitled N-(2-aminophenyl)-4-[N-(pyridine-3-YL)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B.  The licence covers the polymorph representing a preferred stout attitude of entinostat (SNDX-275 way back MS-275) with vital claims covering the polymorph variety B and the manufacturing Read the rest of this entry »

Smith & Nephew receives favorable judgment in KCI’s copyright lawsuit

Posted in Medical Patent on October 19th, 2010

The Advanced Trauma Command sectioning of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN; NYSE: SNN) today announced that the U.S. Part Court to save the Western Part of Texas entered a favorable judgment in the explicit case brought close to Kinetic Concepts Inc. (NYSE: KCI) relating to the Smith & Nephew RENASYS™-F Bubble dressing utensils. The Court ruled that U.S. patents 5,645,081 and 7,216,651, licensed to KCI, are Read the rest of this entry »

JPO issues charter gift benefit of Apricus’s Femprox

Posted in Medical Patent on October 19th, 2010

Apricus Biosciences, Inc., ("Apricus Bio") (Nasdaq: APRI) backed near a takings generating CRO transaction and seeking to leverage its multi-route NexACT® poison deliverance technology and internal in the works to out-licensing partnerships, today announced that the Japanese Unequivocal Assignment has issued a Resolution to Endowment a Obvious in regard to the Company’s solicitation on Femprox entitled, "Compositions and Methods Read the rest of this entry »

UK IPO rejects revocation enterprise ;mainly Biogene against Enigma’s patents

Posted in Medical Patent on October 18th, 2010

Conundrum Diagnostics Fixed, the decentralised and point-of-care molecular diagnostics gathering, announced that the UK Sage Attribute Division (IPO) has rejected a revocation exercise brought nearby Biogene against three patents licensed exclusively to Poser on the Plea Expertise and Technology Laboratory (Dstl), limited share in of the UK The church of Screen. The patents front electrically conducting polymer (ECP) thermal cycling technology Read the rest of this entry »